Skip to main content

Table 1 Patient demographics and baseline clinical characteristics

From: Percutaneous periarticular analgesic injection at one day after simultaneous bilateral total knee arthroplasty: an open-label randomized control trial

 

Additional injection (22 patients/44 knees)

Control (22 patients/44 knees)

P value

Age (years)

77 ± 7

76 ± 7

0.78

Sex (female/male)

19/3

15/7

0.28

Height (cm)

151 ± 5

151 ± 9

0.94

Weight (kg)

59.2 ± 9.1

61.1 ± 9.6

0.50

BMI (kg/m2)

25.8 ± 3.2

26.7 ± 3.5

0.34

Diagnosis (OA/AN)

21/1

22/0

1.00

History of diabetes mellitus (yes/no)

3/19

4/18

1.00

Preoperative VAS at rest (mm)

38 ± 24

32 ± 26

0.26

Preoperative VAS during activity (mm)

46 ± 23

47 ± 24

0.86

Preoperative flexion angle (d)

121 ± 18

119 ± 15

0.74

Preoperative extension angle (d)

− 7 ± 6

− 9 ± 7

0.29

Surgeon (TI/ST/MW)

11/8/3

12/7/3

0.95

Duration of surgery (month)

159 ± 24

157 ± 24

0.80

  1. Abbreviations: BMI body mass index, OA osteoarthritis, AN avascular necrosis, VAS visual analog scale
  2. Note: Results are expressed as means ± standard deviation, unless stated otherwise